ThePICenter.com: A Nationwide Network of Legal Representation for Accidents and Injuries Home | Refer to a Friend | Contact Us | Attorney Log-In
ThePICenter - The Personal Injury Center  

Call us today: 877.888.5936 
 Cases We Handle  Why Choose Us  About Us  Client Services  Frequently Asked Questions   Free Case Evaluation - Submit Your Case
Heparin
Has Heparin Caused You Or A Loved One Harm?
Fill Out The Form Below For A Free Evaluation
 
Areas of Expertise
Accidents
Medical Malpractice
Toxic Substances
Unsafe Drugs
Unsafe Products
 
Have a case, but would like to speak with us directly?
 
Call us today: 877.888.5936
 
Click here to receive your free evaluation
 
Unsafe Drugs :: Heparin

HEPARIN - In February 2008, Baxter International, the primary manufacturer of Heparin in the United States, recalled all of its Heparin products after pressure from the FDA. The FDA believed that at the time at least 400 life threatening reactions and as many as 25 deaths were caused by Baxter's Heparin products.

Heparin is a very popular blood thinner used in surgery and dialysis and thus a big money maker for Baxter. Baxter was aware of the manufacturing defects that caused their Heparin products to cause serious and often fatal reactions, but they were slow to react essentially standing by as more and more people were hurt by their defective drug.

They not only left the drug in circulation longer than it should have been once they were aware of the defects, but they never once inspected their foreign manufacturer's facility to ensure that the drug was being made to specification. It turns out that their foreign manufacturer was not following the necessary procedures nor taking the necessary safety precautions in order to make sure that contaminents don't infuse the drug. Baxter's failure to regulate their foreign manufacturer caused tens of thousands of people to come in contact with a dangerous and defective drug.

Patients that have been given the contaminated Heparin have reported experiencing generalized or localized sensations of warmth, numbness or tingling of the extremities, difficulty swallowing, shortness of breath, audible wheezing, chest tightness, low blood pressure, nausea and vomiting, abdominal pain, diarrhea, dizziness, drug ineffectiveness, dyspepsia, dyspnea, erythema, flushing, headache, hyperhidrosis, hypoesthesia, hypotension, loss of consciousness, malaise, pallor, palpitations, paresthesia, pharyngeal edema, restlessness, tachycardia, and unresponsiveness to stimuli.

The negligence exhibited by Baxter has led thousands of innocent people to experience these serious and often fatal reactions. We intend to hold them accountable for their reckless behavior.

Unsafe drug cases are complex and costly to litigate. Experienced representation is essential, and that is exactly what we help provide. If you believe you or a loved one suffered a serious complication as a result of being administered Heparin, please fill out the form below for a free evaluation. 

Keywords: Heparin Lawsuit | Heparin Lawyers | Heparin Attorneys | Heparin Lawyer | Heparin Attorney
 
 



Free Case Evaluation

Use the form below to submit your case and receive a free evaluation. By submitting this form, you certify that you agree to our Terms and Conditions and want us to contact you regarding your inquiry. Required fields are marked in BOLD.

Your Name:
Your Address:
Your City:
Your State:
Your Zipcode:
Your Email:
Your Phone Number:
Your Fax Number:
Date of Injury:  
Location of Injury:  
If this inquiry is not for yourself, please tell us the name of the person injured:
Your relationship to this person:
 
Details of Injury:
   
Enter the code shown:

Please note, this form may take a few seconds to process after the Submit Case button is pressed.
 


Heparin In the News

Republicans Press FDA Head on Chinese Heparin - Wall Street Journal (blog)
Republicans Press FDA Head on Chinese HeparinWall Street Journal (blog)The Chinese government dropped its investigation of heparin in 2008, and the FDA has all but dropped its own inquiry, the lawmakers said. ...
More Information »



Sanofi fights FDA approval of generic Lovenox - Pharmaceutical Technology Magazine
Kansas City StarSanofi fights FDA approval of generic LovenoxPharmaceutical Technology MagazineThe FDA has approved the first generic version of the blockbuster low molecular weight heparin Lovenox (enoxaparin sodium), much...
More Information »



AM Vitals: FDA Halts New Enrollment in Avandia-Actos Trial - Wall Street Journal (blog)
AM Vitals: FDA Halts New Enrollment in Avandia-Actos TrialWall Street Journal (blog)Heparin Fallout: Two congressmen, citing the FDA, say the Chinese government didn't cooperate in an investigation into tainted heparin...
More Information »



FDA Approves First Generic Blood-Thinner - New York Times (blog)
dBTechnoFDA Approves First Generic Blood-ThinnerNew York Times (blog)Lovenox is made from heparin, a complex mixture of sugar chains derived from the intestines of pigs. The question that has confronted the FDA is whether...
More Information »



China Never Investigated Tainted Heparin, Says Probe - Wall Street Journal
China Never Investigated Tainted Heparin, Says ProbeWall Street JournalWe signed an agreement with the FDA on drug safety in the end of 2007, and strengthened the monitoring of heparin." A spokeswoman for the FDA said...
More Information »



Barton, Burgess probe finds Chinese obstruction in investigation of tainted drug - Dallas Morning News (blog)
Only Kent (blog)Barton, Burgess probe finds Chinese obstruction in investigation of tainted drugDallas Morning News (blog)"As it relates to contaminated heparin, the FDA hasn't done its job and the Chinese government...
More Information »



Congress's heparin "shock" will hamper Hamburg in China - FiercePharma Manufacturing
Congress's heparin "shock" will hamper Hamburg in ChinaFiercePharma ManufacturingSuch an inflammatory charge can only make for more difficult discussions between Chinese drug officials and FDA head Margaret...
More Information »



FDA Approves Generic Version Of Popular Blood Thinner - AHN | All Headline News
FDA Approves Generic Version Of Popular Blood ThinnerAHN | All Headline News... ingredient in the drug is a naturally-derived mixture of sugar molecules known as heparin. Before the FDA can approve a generic version of any...
More Information »



APP Pharmaceuticals Announces Marketing Clearance of Preservative-Free Heparin ... - MarketWatch (press release)
APP Pharmaceuticals Announces Marketing Clearance of Preservative-Free Heparin ...MarketWatch (press release)None of APP's current Heparin Lock Flush Solutions contain benzyl alcohol. "The FDA clearance to market a...
More Information »



Packaging contributes to approval for Sagent's heparin - FiercePharma Manufacturing
Packaging contributes to approval for Sagent's heparinFiercePharma ManufacturingSagent Pharmaceuticals CEO Jeffrey Yordon credits innovative packaging and labeling for the recent FDA approval of nine of the company's...
More Information »



Nuvaring Side Effects - lonad News
Nuvaring Side Effectslonad NewsNuvaRing birth control was approved by the Federal Drug Administration (FDA) on October 3, 2001 and first marketed in the United States in July 2002. ...and more »
More Information »



GTC Biotherapeutics terminates agreement with Ovation Pharmaceuticals ... - Trading Markets (press release)
GTC Biotherapeutics terminates agreement with Ovation Pharmaceuticals ...Trading Markets (press release)The collaboration also plans for further development in larger market acquired antithrombin deficiencies such as the...
More Information »



First FDA/ISMP Fellowship Targets Medication Safety - Pharmacy Practice News (registration)
First FDA/ISMP Fellowship Targets Medication SafetyPharmacy Practice News (registration)Dr. Tu said she was drawn to the field of patient safety advocacy by reports of incidents such as the near-fatal heparin overdoses...
More Information »



India seeks anti-fakes tools to preserve reputation - FiercePharma Manufacturing
India seeks anti-fakes tools to preserve reputationFiercePharma ManufacturingAn example of the latter is its alleged stonewalling in the FDA's investigation into contaminated heparin [see related story]. But driven by the...
More Information »



Abbott to Feature Novel Tests and New Upgrades to Testing Platforms at ... - Trading Markets (press release)
Abbott to Feature Novel Tests and New Upgrades to Testing Platforms at ...Trading Markets (press release)Abbott announced a significant addition to the m2000 system's menu of tests in June with the FDA clearance of a new...
More Information »



(AZN) SqueezeTrigger Price is $47.813. There is $543819684.00 That Short ... - TMCnet
(AZN) SqueezeTrigger Price is $47.813. There is $543819684.00 That Short ...TMCnetOn February 24, 2005, AstraZeneca received the United States Food and Drug Administration (FDA) approval for the heart failure indication....
More Information »



www.StockMarketingInc.com: Get Onboard With Stock Marketing Inc. Today!!! GHII ... - Trading Markets (press release)
www.StockMarketingInc.com: Get Onboard With Stock Marketing Inc. Today!!! GHII ...Trading Markets (press release)PMX-60056, PolyMedix's lead heptagonist compound, is being developed to reverse the anticoagulant activity...
More Information »

 









 
Aviation Accidents| Car Accidents| Truck Accidents| Birth Injuries| Nursing Home Negligence| Mesothelioma| Defective Medical Devices
Copyright 2008 ThePICenter.com. All Rights Reserved.
The Personal Injury Center of AmericaTM is proud to serve clients in New York, Los Angeles, Chicago, Houston, Philadelphia, and throughout the nation.